Lupin gets USFDA approval for manufacturing generic capsules for Biogen's Tecfidera Capsules.
Dimethyl Fumarate is known under the name of Tecfidera patented by Biogen Inc. The drug is indicated for the treatment of patients with relapsing forms of multiple sclerosis.
Lupil company has received the tentative approval from USFDA to market generic version of Tecfidera to market in strengths of 120mg and 240mg.
No comments:
Post a Comment